LIVIA 2.0 : A RCT Of Two French Internet Intervention For Adults Struggling With Prolonged Grief Symptoms

  • End date
    Jun 26, 2023
  • participants needed
  • sponsor
    Debrot Anik
Updated on 26 May 2022
Accepts healthy volunteers


The investigators aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial (RCT).

More specifically, the investigators will test the following primary hypotheses:

  • Both interventions will significantly increase participants' well-being and decrease their distress, and those changes will be stable until follow-up.
  • LIVIA 2.0 will be more efficient than LIVIA 1 on all measure outcomes.
  • LIVIA 2.0 will have less dropouts than LIVIA 1.


Secondary objectives are the following:

  • Participants of LIVIA 2.0 will require less guidance (number of people requesting support and number of e-mails exchanged) than participants in LIVIA 1. The investigators will also explore which session triggers more requests of guidance.
  • Using a monitoring of participants' state throughout the completion of the programme in LIVIA 2.0, the investigators will explore the short-term efficacy of each module on participants' weekly mood, solitude feelings and grief symptoms.
  • The investigators will compare participants' satisfaction in both versions of LIVIA.
  • The investigators will also explore the role of attachment style, type of loss, relationship quality with the partner, the interpersonal closeness with the lost person, symptom severity and level of solitude at onset as moderators of the efficacy of the programmes.
  • The investigators will explore the semantic content of the exercises included in the programme to see if this is related with the improvement over the assessment period.

Condition Prolonged Grief Disorder
Treatment LIVIA
Clinical Study IdentifierNCT05219760
SponsorDebrot Anik
Last Modified on26 May 2022


Yes No Not Sure

Inclusion Criteria

Bereavement or separation/divorce
Either of these events should have happened more than 6 months before participating in the study
Feeling the need for support to cope with the loss (a diagnosis of complicated grief is not necessary)
Age: 18 years or older
Regular Internet access
Mastery of the French language - Approved ICF

Exclusion Criteria

Moderate to acute current suicidality (SIDAS > 19)
Severe psychological or somatic disorders which need immediate treatment
Concomitant psychotherapy
Prescription or change in dosage of psychoactive drugs in the month prior or during the self-help intervention
Inability to follow the procedures of the study, e.g. due to comprehension problems
Enrolment of the investigator, his/her family members, employees, and other dependent persons
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note